Angela L.  Wirick net worth and biography

Angela Wirick Biography and Net Worth

CFO of AtriCure
Angela L. Wirick, C.P.A. was appointed Chief Financial Officer in August 2020. Immediately prior to this, Ms. Wirick served as our Vice President, Finance for four years, where she led the global accounting and finance functions of the Company and supported strategic initiatives. Ms. Wirick joined the Company in 2014 as Director, Finance. Prior to AtriCure, Ms. Wirick began her career in public accounting at Arthur Andersen LLP and Deloitte & Touche LLP, serving clients in a variety of industries over fourteen years. Ms. Wirick received her B.S.B.A. in Accounting from the University of Dayton and is a Certified Public Accountant.

How old is Angela L. Wirick?

Ms. Wirick is currently 46 years old. There are 6 older executives and no younger executives at AtriCure. The oldest executive at AtriCure is Mr. Douglas J. Seith, Chief Operating Officer, who is 58 years old. Learn More on Angela L. Wirick's age.

How do I contact Angela L. Wirick?

The corporate mailing address for Ms. Wirick and other AtriCure executives is 7555 INNOVATION WAY, MASON OH, 45040. AtriCure can also be reached via phone at (513) 755-4100 and via email at [email protected]. Learn More on Angela L. Wirick's contact information.

Has Angela L. Wirick been buying or selling shares of AtriCure?

Angela L. Wirick has not been actively trading shares of AtriCure over the course of the past ninety days. Learn More on Angela L. Wirick's trading history.

Who are AtriCure's active insiders?

AtriCure's insider roster includes Tonya Austin (Insider), Mark Collar (Director), Vinayak Doraiswamy (Insider), Scott Drake (Director), Regina Groves (Director), David Grumhaus, Jr. (Portfolio Manager), Justin Noznesky (Insider), Salvatore Privitera (Insider), Douglas Seith (COO), Sven Wehrwein (Director), and Angela Wirick (CFO). Learn More on AtriCure's active insiders.

Are insiders buying or selling shares of AtriCure?

During the last year, insiders at the medical device company sold shares 8 times. They sold a total of 22,729 shares worth more than $965,162.68. The most recent insider tranaction occured on March, 18th when insider Karl S Dahlquist sold 1,885 shares worth more than $60,621.60. Insiders at AtriCure own 3.0% of the company. Learn More about insider trades at AtriCure.

Information on this page was last updated on 3/18/2024.

Angela L. Wirick Insider Trading History at AtriCure

See Full Table

Angela L. Wirick Buying and Selling Activity at AtriCure

This chart shows Angela L. Wirick's buying and selling at AtriCure by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

AtriCure Company Overview

AtriCure logo
AtriCure, Inc. develops, manufactures, and sells devices for surgical ablation of cardiac tissue, exclusion of the left atrial appendage, and temporarily blocking pain by ablating peripheral nerves to medical centers in the United States, Europe, the Asia-Pacific, and internationally. The company offers Isolator Synergy Clamps, single-use disposable radio frequency products; multifunctional pens and linear ablation devices, such as the MAX Pen device that enables surgeons to evaluate cardiac arrhythmias, perform temporary cardiac pacing, sensing, and stimulation, and ablate cardiac tissue with the same device; and the Coolrail device, which enables users to make longer linear lines of ablation. It also provides cryoICE Cryoablation System that enables the user to make linear ablations of varied lengths; EPi-Sense Systems, a single-use disposable device used for the treatment of symptomatic, drug-refractory, and long-standing persistent atrial fibrillation; cryoSPHERE probe, which provides temporary pain relief by applying cryothermic energy to targeted intercoastal peripheral nerves in the ribcage; AtriClip System, an implantable device coupled to a single-use disposable applier; and LARIAT System, a suture-based solution for soft-tissue closure. In addition, the company sells Lumitip dissectors to separate tissues to provide access to key anatomical structures that are targeted for ablation; Glidepath guides for placement of clamps; Subtle Cannula's to support access for EPi-Sense catheters; and various reusable cardiac surgery instruments. It markets and sells its products through independent distributors and direct sales personnel. The company was incorporated in 2000 and is headquartered in Mason, Ohio.
Read More

Today's Range

Now: $30.42
Low: $29.61
High: $30.58

50 Day Range

MA: $33.33
Low: $28.21
High: $37.78

2 Week Range

Now: $30.42
Low: $27.92
High: $59.61

Volume

542,164 shs

Average Volume

653,468 shs

Market Capitalization

$1.47 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.39